Risk factors for oral cancer, a retrospective study among an Indian population by Wennerström, Lars
  
1 
 
 
 
Risk factors for oral cancer,  
a retrospective study among an Indian population. 
 
 
Degree project thesis in Medicine 
 
 
Student:  
Lars Wennerström 
 
 
Supervisors: 
Daniel Giglio, MD, PhD 
 Department of Pharmacology 
 The Sahlgrenska Academy 
 Göteborg University 
Sweden 
 
Dr.Prathima Sreenivasan, Professor,  
Department of Oral Medicine and Radiology,  
Kannur Dental College 
India 
 
 
 
University of Gothenburg 
And 
Kannur Medical College 
 
 
 
 
 
 
 
 
 
 
 
 
Programme in Medicine 
 
Gothenburg, Sweden 2016 
  
2 
 
Contents 
ABSTRACT ................................................................................................................................................ 3 
INTRODUCTION ....................................................................................................................................... 5 
Oral cancer .......................................................................................................................................... 5 
Risk factors ...................................................................................................................................... 6 
Tobacco ............................................................................................................................................... 8 
Tobacco in India ............................................................................................................................... 9 
Smoking tobacco ........................................................................................................................... 10 
Smokeless tobacco ........................................................................................................................ 10 
Tobacco and cancer ....................................................................................................................... 11 
Alcohol ............................................................................................................................................... 12 
Areca nut ........................................................................................................................................... 13 
Areca nut and cancer ..................................................................................................................... 13 
Human papillomavirus ...................................................................................................................... 14 
Structure and genome ................................................................................................................... 14 
Transmission .................................................................................................................................. 14 
Reproduction and malignancy ....................................................................................................... 15 
HPV and oral cancer ...................................................................................................................... 16 
The immune system and oral cancer ................................................................................................ 16 
Hypothesis of the Master thesis ............................................................................................................ 17 
AIMS ...................................................................................................................................................... 17 
ETHICS.................................................................................................................................................... 17 
METHODS .............................................................................................................................................. 18 
RESULTS ................................................................................................................................................. 20 
DISCUSSION ........................................................................................................................................... 24 
Conclusion and implications .............................................................................................................. 26 
Weaknesses ................................................................................................................................... 26 
Populärvetenskaplig sammanfattning................................................................................................... 28 
REFERENCES .......................................................................................................................................... 30 
APENDIX A – Informed consent ........................................................................................................... 33 
B – Question form ............................................................................................................................. 36 
C – Poster........................................................................................................................................... 40 
 
 
 
  
3 
 
ABSTRACT 
Degree project, Programme in Medicine  
Risk factors for oral cancer, a retrospective study among an Indian population.  
Lars Wennerström, University of Gothenburg, Sweden 2016. 
Introduction 
Oral cancer or oral squamous cell carcinoma (OSCC) is among the most common types of 
cancer in India and strongly linked to habits like smoking- and smokeless tobacco, alcohol 
and Areca nut chewing. In the western world an increasing number of HPV-positive OSCCs 
are diagnosed and differences in the expression of the immune system indicates that the 
pathogenesis of HPV-positive and HPV-negative OSCC differs. 
Aims 
To evaluate risk factors that increase the risk for malignancy in the oral cavity. 
Methods 
Patients were recruited from Kannur Dental College and asked to answer a question form 
about risk habits and medical history. The patients were then examined by a dentist and if 
appropriate, tissue samples were collected for later analysing. 
Results 
19 patients were included in the study. Data analysing only showed significance for 
smokeless tobacco in combination with areca nut (P-value=0.021) as a habit that increases 
the odds (OR= 18.667) for presenting an OSCC.  No tissue swabs were analysed during the 
timeframe for the thesis 
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Conclusions 
The results for smokeless tobacco and Areca nuts highlight the need for a stricter policy (or 
stricter implementation of the existing policy) to reduce the numbers of users. The negative 
results for the other habits is most likely due to the small number of patients included in the 
study. 
Key words 
Oral cancer, oral squamous cell carcinoma, OSCC, India 
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INTRODUCTION 
Worldwide, 14.1 million new cases of cancer were diagnosed in 2012 and 8.2 million people 
died because of cancer.  The most common cancers are lung (1.82 million), breast (1.67 
million) and colorectal (1.36 million). The cancer form causing most deaths are lung (1.6 
million deaths), liver (745,000 deaths), and stomach (723,000 deaths (1). 
Oral cancer 
Oral cancers ranks as the 15th most common cancer worldwide, with an incidence in 2012 
around 300.000 new cases, i.e., 2.1% of the total new cancer cases in the world and with two 
thirds of cases occurring in men. Each year 145.000 people (1.8% of the total cancer deaths in 
the world) die from oral cancer (2). Oral cancer is more common in the countries of the 
Pacific and South Asia than in Europe and North America (3). The majority (95%) of oral 
cancers that are diagnosed today in the world is oral squamous cell carcinoma (OSCC) (1, 2). 
OSCC is often, but not always, preceded 
by a pre-malignant lesion, this is more 
often the case with OSCCs that are caused 
by habits such as alcohol and tobacco. 
Leukoplakia, the most common of the pre-
malignant lesions, presents itself like a 
white plaque in the oral epithelium. 
Studies have shown that when biopsied, 
20% of the leukoplakia contain epithelial 
dysplasia, and when positioned in the 
floor of the mouth or the tongue, the ratio was 
over 40% (4). 
Figure 1: Leukoplakia in the roof of the mouth. 
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OSCC caused by habits such as tobacco and alcohol use is usually found in the lateral and 
dorsal sides of the tongue and in the floor of the mouth (4), while human papilloma virus 
(HPV)-associated OSCC occurs more frequently in the tonsils and in the base of the tongue 
(5, 6). OSCC is typically presented as a red, white or speckled lesion, often with a central 
ulceration if the OSCC is of a more advanced stage (4).  
 
Figure 2: OSCC on the right lateral side of the Tongue. 
        
In India 70.000 new cases are diagnosed and 48.000 people die of OSCC each year (7-9), 
being the second most common cancer among men and the fourth among women. It is, 
however, estimated that even more patients are affected by OSCC since there is no 
compulsory registration of oral cancer in India and a lot of people have limited access to 
healthcare (8). 
Risk factors 
Smoking, tobacco chewing and high alcohol consumption are all major risk factors for OSCC 
(8, 10-13) and the chewing of Areca nut has been strongly linked to OSCC in countries where 
this habit is common, for example India (8, 12, 14). Viral infections, especially those caused 
by HPV type 16, also belong to the risk factors (8, 11-13) and HPV-associated OSCC are 
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associated with oral sex practice and multiple sexual partners (6, 14-16). It is likely that the 
pathogenesis of HPV-associated OSCC differs from OSCC caused by tobacco and alcohol 
use. First, HPV-positive OSCCs usually affect a younger population. Secondly, habits such as 
high alcohol consumption, tobacco and chewing of betel nut are less common among patient 
with HPV-positive OSCC (13, 16). Thirdly, the prognosis for patients with HPV-positive 
cancers is better than for non-HPV associated OSCC (16, 17). 
Studies in India show that the risk for OSCC increases five times when chewing tobacco 
among non-smokers and that as much as 50% of all OSCC are caused by smokeless tobacco 
products (18). In a 24 month study, 35.112 individuals from Sangli in Western Maharashtra (a 
semi-urban district in India) were screened for OSCC and habits of smoking, chewing tobacco 
and drinking alcohol. 112 cases of oral cancer were found giving it a prevalence of 0.3% 
among the study population. Subgroup analyses of individuals with habits of smoking, 
tobacco chewing and/or drinking alcohol showed a prevalence of oral cancer of 1.12% (19). 
Heredity and genetic predisposition are thought to constitute minor risk factors for the 
development of OSCC. Instead factors such as chronic inflammation, DNA-damage, neo-
angiogenesis and alterations in the host immunity are considered as major contributors to the 
development of OSCC (8). 
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Tobacco 
There are about 70 different species of the tobacco plant (Nicotiana), but few of them are used 
in tobacco products. Commercial tobacco products usually contain the Nicotiana tabacum or 
N. rustica which is common in South America, Africa and Asia, where it is used in smokeless 
tobacco products. N. rustica contains more nicotine and alkaloids than N. tabacum (20-22). 
According to the World Health Organization (WHO) we have approximately 1.1 billion 
smokers in the world, which gives smoking a prevalence of around 22%. Smoking is more 
common among men (37%) than women (7%). There are several ways of smoking tobacco, 
although 90% of smokers use the manufactured cigarette (10). Tobacco has a considerable 
impact on global health and constitutes the most important preventable risk factor for an early 
death. It is estimated that 6 million people die because of tobacco use and another 600.000 
from second-hand smoking (10). 
The prevalence of smoking has decreased from 41% in 1980 to 31% in 2012 for men and 
from 11% to 6% for women. The actual number of smokers though, has increased from 721 
million to 967 million during the same period due to the increase in the worldwide population 
(23). 
The data available on the consumption of smokeless tobacco makes it difficult to correctly 
describe its global use to this day (10). In 2010, in a survey that represented about 70% of the 
world population, it was estimated that over 300 million people were using smokeless tobacco 
(19), a number being reinforced by WHO, which also states that 90% of the smokeless 
tobacco users lived in the South-East Asia region (24) and in some of these countries, the use 
of smokeless tobacco even exceeds that of smoked tobacco (10). 
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Tobacco in India 
In 2010, 35% of the Indian population used tobacco of some form; smokeless tobacco (60%), 
smoking tobacco (25%) and both methods (15%). Tobacco consumption is more common in 
rural (38%) versus urban areas (25%). The habit is more widespread among men where 48% 
is using tobacco compared to 20% in women. Education is another factor where 44% of the 
population with no formal education was using tobacco compared to 21% of those with 
secondary or higher education. The young population aged 15-24 years showed the lowest 
consumption of tobacco (18%), while people 65 of age and older had the highest percentage 
smokers (48%). The tobacco industry is very large in India and employs millions of people 
(25). 
For comparison; in 2014 in Sweden, 22%% of the Swedish population was using tobacco on a 
daily basis, 48% used smoking tobacco, 48% smokeless and 2% was using both (26). 
In India, smoking tobacco is much more common among men (24%) than women (3%) (25, 
27). There are significant differences between states in India with a smoking prevalence 
ranging from 24-62% among men and 1-25% among women (28). Overall, the most popular 
smoking product was the Bidi (60%) followed by the manufactured cigarette (40%) and 
hookah (less than 1%) (25). 
In 2010 the numbers of smokeless tobacco users in India were over 220 million, or 26% of the 
population (9, 20, 25). The most popular product of smokeless tobacco in India is Khaini 
(46%), followed by Guthka (31%) and the betel quid (23%) (25). In contrast to smoking 
tobacco, the consumption of smokeless tobacco is more equal among men and women (20% 
and 17%, respectively). In rural areas, 29% are using smokeless tobacco compared to 18% in 
urban areas (20, 25). As with smoking tobacco, the percentage of people using smokeless 
tobacco varies between states in India with prevalence varying between 12-68% among men 
and 2-64% among women (28).  
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Smoking tobacco 
The most common way to smoke tobacco in India is the cigarette (22), although the Bidi is 
also very popular. The Bidi is a thin, sometimes slightly conical cylinder made out of the leaf 
of the temburni or tendu plants. The cylinder is filled with tobacco and is quite similar to a 
cigarette. It is hand-rolled and secured in one or both ends with a string (22, 29, 30). The 
water pipe, or Hookah in India, is gaining popularity again after a decline, especially among 
young people. In many Western countries, it is only the cigarette that is more common, and in 
some Middle Eastern countries the Hookah is the primary way to use smoking tobacco (30-
32).  
 
Figure 3: From left to right: Manufactured cigarette, Bidi and Hookah 
 
Smokeless tobacco 
Thera are a multitude of variations of smokeless tobacco in the world with different countries 
and areas having their own types. Smokeless tobacco is usually held in the mouth and chewed 
or sucked upon, but can also be taken nasally. Common variations in India are Khaini, Guthka 
and Betel Quid. The contents of these are tobacco in some form and slaked lime to raise the 
ph. Areca nut is usually added as is spices, flavorings and sweeteners and in the case of Betel 
Quid, all the contents are wrapped up in a betel leaf (hence the name) making a small sachet 
that is then placed in the mouth. Products like Khaini and Guthka are made both 
commercially or by a large cottage industry, while the Betel Quid is always made on demand 
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by the provider or user. There are lots of laws in India meant to regulate and even outlawing 
some of the versions of smokeless tobacco, but these laws are rarely enforced to the point that 
it makes any difference (20). 
 
Figure 4: Left; Betel Quid or Paan, right; Guthka. 
 
Tobacco and cancer 
There are about 4000 different chemical components in tobacco that are considered harmful to 
various degree. For the development of cancer, the tobacco-specific nitrosamines (TSNAs), 
are considered the most potent due to the high concentration of them in tobacco. International 
Agency for Research on Cancer (IARC) has classified two of the TSNAs as IARC group 1 
carcinogens, i.e., N’-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK) which are believed to be major contributors in the development of oral 
cancer (20). 
During growth, the tobacco plant will synthesize alkaloids, for example nicotine, from 
compounds absorbed by the soil. The alkaloids are the most important precursors of TSNAs. 
Nitrate (NO3
-) in the tobacco and microorganisms, bacteria and fungi, on the leaves will 
facilitate the conversion of alkaloids to TSNAs. During the manufacturing process the 
microorganisms will proliferate and convert the nitrate to nitrite (NO2
-) which in turn will 
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react with the alkaloids in the tobacco, generating TSNAs. The amount of microorganisms on 
the tobacco leaves during the manufacturing process is the most important factor for the final 
content of TSNAs. This has been proved by using different manufacturing methods, such as 
pasteurization, which reduce the number of bacteria and fungi on the tobacco. This will in 
turn reduce the transformation of nitrate to nitrite, resulting in lower concentrations of TSNAs 
in the end product (20). 
Besides inducing addiction to tobacco, nicotine is an alkaloid and a precursor to TSNAs, and 
as such, one of the major contributors to the levels of NNN and NNK in the finished product. 
Nicotine exists in bound (ionized and mono-proponated or di-proponated) and free (un-
ionized or un-protonated) form in tobacco. The total nicotine is normally declared on the 
tobacco product, i.e., both the bound and free nicotine are declared. It is the free, uncharged, 
form that is the most active since it can pass through cell membranes more easily. The amount 
of free nicotine in a tobacco product is determined by the pH, i.e., the higher the pH, the 
higher the amount of free nicotine (20). 
Alcohol 
On average, every adult in the world consumed 6.2 liters of pure alcohol in 2010. The highest 
consumption is found in middle- to high-income countries in Europe and North America. It 
should also be taken into consideration that 48% of the global population has never consumed 
alcohol, so the consumption will vary considerable between regions and countries. 
Worldwide, 3.3 million deaths, or 5.9% of all deaths, were related to the alcohol consumption 
in 2012 (10, 33). 
According to a WHO global report on alcohol the average consumption for an Indian adult 
was 4.2 liters of pure alcohol per year during the years of 2008-2010. But in India 74% of the 
population is lifetime abstainers, (59% of men and 90% of women) and 13% (16% of men 
and 5% of women) are former drinkers (people that have not consumed alcohol the last 12 
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months). Taking this into the equation the actual alcohol consumption among people that 
drink is much higher, i.e., 28.7 liters of pure alcohol per year and (drinking) person. In 
comparison, a Swedish adult consumes 13.3 liters of pure alcohol per year when adjusted for 
abstainers.  The type of alcohol consumed in India is dominated by spirits (93%), followed by 
beer (7%) and wine (<1%) (33), again, as comparison when translated to pure alcohol, in 
Sweden wine stands for the bulk of the consumption (42%), followed by beer with an alcohol 
content over 3.5% (30%), liquor (22%), beer with an alcohol content up to 3.5% (5%) and 
cider and premade alcoholic drinks (1%) (34). 
Areca nut 
Areca nuts come from the Areca palm (Areca catechu) which grows in South-east Asia and 
Eastern Africa. It is used as an ingredient in smokeless tobacco products as well as on its own. 
The nut can be used as it is, without any preparation or dried, roasted or baked. Before 
consumption the nut will usually be cut into small slices or cubes or crushed (20, 35, 36). 
Worldwide, Areca nut is one of the four most commonly used psychoactive substances with 
600+ million users (3, 36-38), the other three are caffeine, nicotine and alcohol (36, 38, 39). 
Most of the users come from East Asia, South-East Asia and Africa. Immigrants from these 
regions have also brought the habit to their new countries. For example, Great Britain is the 
largest importer of Gutkha outside Asia and in the USA, both Betel Quid and Gutkha is legal 
and the consumption there is increasing (36). The top consumer in the world is India (36), and 
the prevalence there ranges from 3% to 29% depending on which state you are looking at 
(28). 
Areca nut and cancer 
The Areca nut is an IARC group 1 carcinogen. It contains the compounds guvacoline and 
arecoline which when reacting with nitrate or during chewing form areca-specific nitrosamine 
compounds (ASNAs) such as N-nitrosoguvacoline (NGL) and 3-(N-nitrosomethylamino) 
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propionaldehyde. The latter of these are proved highly genotoxic as well as cytotoxic to 
buccal mucosal epithelial cells in humans, partly explaining why Areca nut users are 
overrepresented among OSCC patients in countries where this habit is common (20, 37, 40). 
When combined with other ingredients the carcinogenic properties can be increased further. 
For example, slaked lime will, when combined with areca nut, form reactive oxygen species 
(ROS) which will lead to oxidative damage to DNA (37). 
 
Human papillomavirus 
There are more than 150 different sequenced phenotypes of the Human papillomavirus (HPV) 
(41). 
Structure and genome 
The HPV is a 52-55nm non-enveloped virus.  Its genome contains double-stranded DNA with 
approximately 8000 base pairs. The genome encodes for about 8 open reading frames divided 
in three parts, early, middle and late expression genes. Proteins needed for replication, viral 
transcription and cellular transformation are expressed early, and hence the name “E #” for 
these proteins. Proteins needed later in the virus cycle (denoted L#) are those for assembly of 
the virus, e.g., the capsid proteins L1 and L2 (13). The cell cycle progression is stimulated by 
the proteins E6 and E7 and differences in the expression of these proteins decide if a HPV is a 
high- or low risk oncogenic phenotype of HPV. High risk HPV includes HPV-16, 18, 31, 33, 
35, 45, 51, 52, 56, 58 and 59 (13, 41). 
Transmission 
The favored sites for the HPV to infect are the squamous epithelial cells and usually the basal 
cells of the tonsils, oropharynx, cervix, vagina, vulva, penis, perianal area and anal canal (13, 
42). In the case of oral transmission there are multiple ways of infection such as autoinfection, 
open mouth kissing and sexual transmission. Rare cases of perinatal transmission of HPV 
have been observed as well (13). 
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Reproduction and malignancy 
After gaining entry to the cell, to maximize viral reproduction the HPV must increase the 
proliferation rate of the infected cell. Initially only a few copies are made of each virus and 
these viruses are forming the base for the latent part of the infection. In the productive phase 
of the infection viral proteins are produced at a much higher rate, regulated by the E1 and E2 
proteins. In the case of high risk (HR)-HPV infection, E6 and E7 are also expressed with E6 
preventing apoptosis and E7 making the cell DNA replication cycle available for viral DNA 
production by enabling the cell to re-enter the S-phase of the cell cycle. This means that the 
epithelium will start to proliferate thereby creating an increasing number of HPV infected 
cells that may result in an intraepithelial or invasive neoplasm. By the help of the E1 and E2 
proteins, the virus eventually leaves the infected cells and can infect new ones (13).  
When causing a malignancy, the viral genome breaks during integration at the site for the E1 
and E2 proteins, resulting in a loss of control of the E6 and E7 proteins, which in turn will be 
directly involved in the cell cycle by removing the influence of p53 and pRb (10, 43). The E6 
protein binds to p53, inhibiting the cells ability to go into apoptosis. E7 interacts with pRb, 
removing its ability to prevent the cell cycle moving from the G1 phase to the S phase, 
promoting cell proliferation. In conclusion, by working together, the E6 and E7 proteins can 
induce uncontrolled cell growth, while preventing normal apoptosis of cells (2, 10, 42, 51). As 
a result of this, mutations of the p53 gene are rare among HPV positive tumors when 
compared to the HPV negative ones, indicating that it is the direct influence of the HPV that 
causes HPV positive malignancies (10). 
HPV infections are responsible for about 5% of all cancers worldwide, which translates to 
over 600.000 new cancer cases each year. HPV has more impact on less developed countries, 
where it is responsible for 7% of the new cancer cases compared to 2% for the developed 
countries. The majority of these HPV-related cases is cervical cancer (85%) but the incidence 
of other cancers such as OSCC is increasing worldwide (43). 
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HPV and oral cancer 
In contrast to cervical cancer that may be caused by multiple HPVs, HPV-16 dominates in 
HPV-associated OSCC (6, 13, 14, 43). As mentioned earlier, HPV-associated OSCC occurs 
most frequently in the tonsils and in the base of the tongue (5, 6, 14, 44). However, dormant 
infections of HPV in the tonsils are uncommon in patients undergoing tonsillectomy for 
benign causes (5, 44). It is at present not understood why HPV-positive tonsillar cancers are 
common but dormant infections of the tonsils are uncommon. One reason could be that 
dormant infections are difficult to detect in the tonsils or that tonsils are rarely infected by 
HPV but when HPV infection occur, cancer is easily developed (43). 
 
The immune system and oral cancer 
Toll-like receptors (TLRs) and nod-like receptors (NLRs) belong to pattern recognition 
receptors (PRRs) and play crucial roles for the innate immune response. PRRs are expressed 
on immune cells and different tissues including the oral mucosa and are important for 
recognition of antigens of pathogens and molecules of damaged cells. TLRs are known to be 
activated by “damage-associated molecular patterns” (DAMPs) that are released from 
stressed, dying or dead cells. Many clinical trials are now focusing on how to boost the 
immunological response in order to eradicate tumors by targeting TLRs (45). NLRs recognize 
molecular patterns of pathogens after e.g. tissue damage (46). 
The innate immune system seems to play an important role for the development OSCC. TLRs 
are expressed in OSCC (47, 48), and, studies show that higher expression of TLR5 in oral 
tongue squamous cell carcinoma is associated with increased recurrence rate (49). TLR5 is 
activated by bacterial flagellin and TLR5 has therefore been suggested to be the link between 
bacterial infection and the development of carcinogenesis (50). Animal models suggest that 
HPV vaccines targeting TLRs besides HPV may be beneficial in the therapy of already 
established HPV-associated cancers (51). 
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Hypothesis of the Master thesis 
Smoking, chewing tobacco and/or Areca nut and overuse of alcohol increase the risk of 
developing OSCC. 
 
AIMS 
 To evaluate risk factors that increase the risk for malignancy in the oral cavity. 
 
ETHICS 
 The Helsinki declaration regarding ethical principles for medical research involving 
human subjects was taken in consideration when conducting this study.  
 The study was approved by the Kannur medical college hospital ethical committee. 
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METHODS 
The original design of the study were to include two groups of patients:  
1.  A study group recruited from the patients receiving care at the Malabar Cancer 
Centre in Kannur, a hospital treating oncology patients exclusively. The patients from this 
hospital had a present use or history of habits that are considered risk factors for OSCC, i.e. 
alcohol and/or tobacco and/or areca nut consumption and one or more clinical and/or 
histopathological verified malignant lesion/lesions in the oral cavity. 
2.  A control group recruited from patients that were seeking care at the dental 
clinic at the Medical and Dental Hospital of Kannur, the dental clinic treated patients with a 
wide variety of diagnoses. As for the study group, the inclusion criteria were that the recruited 
patient to the study had a present use or history of habits that are considered risk factors for 
OSCC, but in the case of the control group, there was no demand for a verified malignant 
lesion in the oral cavity.  
The data collected from the study- and control group would then be matched against each 
other, using IBM SPSS Statistics version 22. 
Unfortunately, due to unforeseen circumstances (a missing memorandum of understanding), 
the project plan could not be forwarded to the ethical committee at the Malabar Cancer Centre 
and we were therefore unable to include patients from that hospital in the study.  
Therefore, the patients recruited from the dental clinic at the Medical and Dental Hospital of 
Kannur was instead divided into two groups, one with one or more premalignant or malignant 
lesions in the oral cavity, and one with non-malignant or no lesions in the oral cavity. Once 
included, there were no exclusion criteria unless the patient decided to end his or hers 
participation in the study. The data collected would then be matched against each other, using 
IBM SPSS Statistics version 22. 
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Patients included in the study were given information about the study before signing an 
informed consent form (appendix A) and filling out a questionnaire (appendix B) for 
obtaining anthropometric data about tobacco-, alcohol-, areca nut habits and a short medical 
history. A witness was present to translate the content of the informed consent and health 
information to Malayalam. After the questionnaire the patients underwent an oral examination 
by a dentist at the department of oral medicine. Any findings of lesions were registered in the 
health information form.  
Tissue swabs were taken for later HPV analysis. If a malignant lesion was present, the 
samples were collected from both the tumor (HPV+ and HPV-) and from the healthy 
contralateral side in the mouth. Patients without malignant lesions underwent swabbing of the 
tonsillar area, the basal part of the tongue, the buccal mucosa, the hard palate, the side of the 
tongue and the lip. The equipment used to take the samples were “Isohelix™ SK1 DNA 
Buccal Swabs (Cell Projects Ltd. Harrietshan, Kent, UK). The samples were then marked 
with a unique identification code and stored in a freezer. The samples will later be analyzed 
with RT-PCR for a panel of inflammatory markers within the innate immune response. 
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RESULTS 
In the period 2016-02-25 to 2016-04-05 19 patients were identified as viable for the study, 
i.e., presented one or more of the risk factors for OSCC, and asked to participate. 18 of the 
patients were seeking dental care at the dental clinic at Kannur dental college and 1 patient 
was recruited during a free dental camp in the town of Kannur. The age of the patients ranged 
from 19 to 87 years with a mean value of 53.2 years. Of the 19 patients, 16 were men and 3 
women. 7 (36.8%) of these patients presented no lesions at all (having sought dental help for 
other reasons, for example, adjusting dentures and damaged teeth from working accidents), 3 
(15.8%) presented non-malignant lesions, 6 (31.6%) pre-malignant lesions and 3 (15.8%) 
presented histopathological verified malignant lesions. The men showed an equal distribution 
among the no-/non-malignant and the pre-malignant/malignant lesions while all of the women 
had pre-malignant or malignant lesions. 
Chart 1: Different lesions in men and women 
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Of the 19 patients, 15 (78.9%) were using smoking tobacco, 6 (31.6%) were drinking alcohol, 
8 (42.1%) were using smokeless tobacco and 9 (47.4%) were using Areca nut.  
Chart 2: Habits shown by test subjects.
 
 
When looking for trends according to age the patients was divided in two groups; under and 
over mean age (53.2years). Except for the finding that drinking alcohol is twice as common in 
the older group with 4 patients versus the 2 patients in the younger group, no specific trends 
could be found this way as shown in table 1. 
Table 1: Habits within age groups. 
Habit Under mean age Over mean age 
Yes No Yes No 
Smokeless (8) 4 5 4 6 
Smoking (15) 8 1 7 3 
Alcohol (6) 2 7 4 6 
Areca nut (9) 5 4 4 6 
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Analysing combinations of habits showed that 5 patients (26.3%, all men) were using 
smoking tobacco only, 5 (26.3%, all men) was using both smoking tobacco and alcohol,  4 
(21.1%, all men) were using both smoking and smokeless tobacco and chewing areca nut, 3 
(15.8%, all women) were using smokeless tobacco and chewing areca nut, 1 (5.3%, all men) 
was using alcohol,smokeless tobacco and chewing Areca nut and 1 (5.3%, all men) was using 
smoking tobacco and chewing Areca nut.  
Chart 3: Combination of habits shown by patients (total). 
 
The most common combination of habits was to use smokeless tobacco together with Areca 
nuts and vice verse  (8 out of 8. Alcohol on the other hand was raraly used in combination 
with smokeless tobacco or Areca nut (1 out of 6). 
Table 2: Common and uncommon combinations of habits shown by patients (individual). 
Habit Smokeless (8) Smoking (15) Alcohol (6) Areca Nut (9) 
Yes No Yes No Yes No Yes No 
Smokeless 
(8)  
X X 5 
(62.5%) 
3 
(37.5%) 
1 
(12.5%) 
7 
(87.5%) 
8 
(100.0%) 
0 
(0.00%) 
Smoking (15) 5 
(33.3%) 
10 
(66.7%) 
X X 5 
(33.3%) 
10 
(66.7%) 
6 
(40.0%) 
9 
(60.0%) 
Alcohol (6) 1 
(16.7%) 
5 
(83.3%) 
5 
(83.3%) 
1 
(16.7%) 
X X 1 
(16.7%) 
5 
(83.3%) 
Areca Nut 
(9) 
8 
(88.9%) 
1 
(11.1%) 
6 
(66.7%) 
3 
(33.3%) 
1 
(11.1%) 
8 
(88.9%) 
X X 
5
5
4
1
1
3
0 1 2 3 4 5 6
Smoking tobacco
Smoking tobacco and alcohol
Smoking-/smokeless tobacco and Areca nut
Smokeless tobacco and Areca nut
Alcohol, smokeless tobacco and areca nut
Smoking tobacco and Areca nut
FREQUENCY
C
O
M
B
IN
A
TI
O
N
S 
O
F 
H
A
B
IT
S
Men Women
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The variables tested for statistical significance to increase the odds for the patient to present a 
pre- or malignant (OSCC) lesion was; age, gender, smoking tobacco, alcohol consumption, 
chewing smokeless tobacco and chewing areca nut. When tested alone, chewing smokeless 
tobacco and Areca nuts showed statistical significance while age, gender, smoking tobacco 
and alcohol consumption did not. But, as stated earlier, all of the patients chewing smokeless 
tobacco also chewed Areca nuts, which means the results for smokeless tobacco and Areca 
nut cannot be interpreted on their own.  
Table 3: Statistical analysis of habits. 
 
 
 
 
 
 
Habit P-value Odds ratio 
Age 0.080 1.051 
Gender 0.999 0.000 
Smoking tobacco 0.999 0.000 
Alcohol 0.262 0.313 
Smokeless tobacco 0.021 18.667 
Areca nut 0.047 8.167 
Smokeless tobacco and Areca nut (in combination) 0.021 18.667 
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DISCUSSION 
The aim of the study was to evaluate the risk factors for developing an oral malignancy in an 
Indian population.  
It should be noted from the start that it is difficult to interpret the results for significance and 
odds ratios because of the small number of test subjects. Despite this, it was decided to 
include them since at least some of them showed similarities to prior research, and for those 
who did not, it was interesting to speculate why. 
Our findings show that the consumption of smokeless tobacco and Areca nuts increase the 
odds for presenting a pre-malignant or malignant lesion in the oral cavity. This is consistent 
with, and reinforce, the results from multiple prior studies (8, 10-13). But since all the 
smokeless tobacco users also used areca nuts it was not possible to say anything about the 
individual results for these factors and they had to be analyzed together. The reason for this is 
that the most popular smokeless tobacco products in India also contain areca nut and it is rare 
to chew areca nut on its own, and therefore smokeless tobacco and areca nut are usually used 
together. The odds ratios presented was very high, especially for the combination of 
smokeless tobacco and areca nut (or smokeless tobacco on its own) but this phenomena be 
attributed to the low amount of patients included in the study. It may also be because of an 
additive or synergistic effect of using smokeless tobacco in combination with Areca nut as 
suggested by Garg et. al. (37),but larger studies are needed to confirm this.  
Age seemed to be a rather low risk factor in this study. This is most likely dependent on the 
small number of patients included in the study when a single younger patient presenting a pre-
malignant or malignant lesions will heavily affect the odds ratio of age. Previous data from 
other studies, among others by Gupta et. al. (8), show that the typical patient with OSCC in 
India is of higher age since the malignancy is usually caused by habits and is not HPV-
associated as in western countries where OSCC is affecting a younger population .With a 
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larger study sample, age would most likely show significance and a higher odds ratio. Since 
there was little difference in specific habits when different age groups was put against each 
other we can draw no conclusions that age would have any impact on the probability for an 
individual to show certain habits, indicating that the use smokeless and smoking tobacco, 
alcohol and Areca nut are evenly spread in our study population.  
Despite alcohol consumption as a variable not being significant, its protective ability shown in 
this study should be adressed. This is likely due to that alcohol consumers are less prone  to 
chew smokeless tobacco and Areca nuts, the two factors that were over-represented among 
the patients with pre-malignant and malignant lesions and as prior Indian studies (8, 10-13) 
has shown, greatly increse the risk for OSCC. That smoking and gender did not show 
significance or any odds ratio at all is most likely again attributed to the small study sample 
size.  
The fact that all the women all presented premalignant or malignant lesions is most likely 
explained by all of them also combining chewing tobacco and Areca nut, the main risk factors 
in India for not only oral cancer, but also for pre-malignant lesions like Leukoplakia as 
explained by Kademani (4). 
Although, one can speculate that since smoking is a known risk factor for, and men are twice 
as likely to be affected by, OSCC, in this study where only patients with habits were included, 
smoking, gender and alcohol (that has indicated a protective ability in this study) are the 
“lighter” habits while chewing smokeless tobacco and Areca nuts and maybe age are the 
“severe” habits and more prone to result in a patient presenting a pre-malignant or malignant 
lesion. But to prove this, a study with a signiffically higher number of test subjects and with a 
control group without habits of risk factors must be conducted. 
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Conclusion and implications  
India as a country stand before a challenge to reduce the usage of products that are known to 
cause OSCC and the laws already in place needs to be enforced more firmly.  
Part of the problem though, is that the tobacco and Areca nut industry is very large and 
employs a lot of people, usually with a lower socioeconomic status. New jobs need to be 
created for these people, making it a political “hot potato” that few wants to handle. That 
some of the smokeless tobacco/Areca nut products are deeply rooted in Indian culture, like the 
Betel Quid, does not make it any easier. 
 
Weaknesses 
The obvious weakness that has already been addressed is the small size of the study 
population since this means that single patients will have an unproportioned effect on the 
statistical outcome. The reason for this was partly the fact that we could not recruit any 
patients from the Malabar Cancer Center as planned in the original study design. Hopefully, 
following projects will be able to include patients from this hospital since this design will 
supply a study with a large study group when researching patients with malignancies. The 
other part is most likely, that when it comes to studies about lifestyle factors that are 
associated with stigma of some sort, such as tobacco, alcohol, and for most people in India 
today, Areca nut chewing there will be a risk of underreporting or not admitting use at all. 
This is especially true if the patient in question are seeking help for some problem that are 
obviously not related to habits, like in this study, where some of the patients was seeking help 
for work-related injuries to the teeth or needed adjustment of their dentures. Because of this, it 
is likely that the actual number of patients, with one or more of the risk habits, seeking care at 
the dental clinic was higher than the ones actually recruited. How to address this problem is 
hard to say since it has to do with social stigma and the fear from the patients that their level 
of care will be affected if admitting to these habits. 
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Since the question form was in english it needed to be translated to malayalam, this was not 
done by a professional interpreter which means that all information in the form may not 
always been presented to the patient. It should be noted that the translation was always done 
by a professional dentist with good English and native Malayalam langue skills. 
If repeated, the original study design would probably give a good view of the respective 
danger of the risk factors for developing oral cancer, if given access to the Malabar Cancer 
Centre patient pool this would most likely provide a large enough study group. Another way 
to recruit a large enough control group with the difficulties encountered in this study might be 
to try to recruit them from patients that are seeking help to quit their habits as classes are 
being held for this reason, but unfortunately we were not able to try to try this strategy during 
the time this study was conducted. 
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Populärvetenskaplig sammanfattning  
Munhålecancer, en studie om riskfaktorer i Indien. 
Munhålecancer är en mycket vanlig form av cancer i Indien, den nästa vanligaste för mån 
och den fjärde vanligaste för kvinnor, som jämförelse så kommer den på 15:e plats bland alla 
cancerformer. I Indien är munhålecancer starkt förknippad med livsstilsvanor som rökning, 
hög alkoholkonsumtion, att tugga tobak och Areca nötter. Att tugga tobak och Areca nötter 
är vanligt i Indien och resten av Sydostasien och är bevisat cancerframkallande. Många olika 
former av tuggtobak och Areca nötter är förbjudna i Indien men dessa förbud har liten effekt 
då de vanligtvis inte beivras. Över 200 miljoner människor i Indien använder tuggtobak 
dagligen och majoriteten av dessa tuggar också Areca nötter. 
Den här studien gjordes för att undersöka och bekräfta sambandet mellan livsstilsvanor och 
munhålecancer bland Indier och samla in information om detta. Studiedeltagarna 
rekryterades på plats vid Kannur Medical College i delstaten Kerala i Indien. De besvarade 
frågor om livsstilsvanor och sjukhistoria samt undersöktes av en tandläkare. Om man hittade 
något i munhålan som kunde misstänkas vara cancer eller ett förstadium till cancer så togs 
det vävnadsprover av dessa för senare analys. 
19 deltagare inkluderades I studien. När informationen från frågorna analyserades så fann 
man en starkt ökad chans att ha en munhålecancer eller förstadium till detta om man 
tuggade tobak tillsammans med Areca nötter. Resultatet stämmer bra överens med tidigare 
forskning i ämnet och belyser nödvändigheten av en strikta regler för tobak och Areca 
nötter, eller att de lagar som redan finns beivras, för att minska antalet användare. 
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Den här studien kunde inte bevisa ett samband mellan alkoholkonsumtion eller rökning och 
munhålecancer, detta var antagligen på grund av att antalet deltagare var så lågt. Studier 
med större antal deltagare behövs för att mer exakt bevisa riskerna. 
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APENDIX 
A – Informed consent 
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B – Question form 
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C – Poster 
 
 
